FK 506 FOR LIVER, KIDNEY, AND PANCREAS TRANSPLANTATION
نویسندگان
چکیده
منابع مشابه
FK 506 for liver, kidney, and pancreas transplantation.
FK 506 was given for immunosuppression in 14 liver recipients. The drug was used in the first 10 cases because the recipients under conventional immunosuppression had rejection, nephrotoxicity, or both. This salvage therapy was successful in 7 of the 10 attempts. 2 of the 10 patients in the original salvage group as well as 4 new patients underwent fresh orthotopic liver transplantation under F...
متن کاملKidney transplantation under FK 506.
The experimental immunosuppressive drug FK 506 was given to 36 renal transplant recipients, many of whom were highly sensitized. Ten were undergoing kidney retransplantation, 10 also underwent liver transplantation at an earlier time (6 patients) or concomitantly (4 patients), and 2 patients received a third organ (heart or pancreas) in addition to a liver and kidney. With follow-ups of 4 to 13...
متن کاملLiver, kidney, and thoracic organ transplantation under FK 506.
The new immunosuppressive drug FK 506 was used from the outset with low doses of prednisone to treat 120 recipients of primary liver grafts and 20 more patients undergoing liver retransplantation. The patient survival rate after 2 to 8 months in the primary liver transplantation series is 93.3%, with original graft survival of 87.5%. Of the 20 patients in the hepatic retransplant series, 17 (85...
متن کاملPreliminary Communication Kidney Transplantation Under FK 506
The experimental immunosuppressive drug FK 506 was given to 36 renal transplant recipients, many of whom were highly sensitized. Ten were undergoing kidney retransplantation, 10 also underwent liver transplantation at an earlier time (6 patients) or concomitantly (4 patients), and 2 patients received a third organ (heart or pancreas) in addition to a liver and kidney. With follow-ups of 4 to 13...
متن کاملKidney transplantation under FK 506 immunosuppression.
W E RECENTLY reported our initial experience with FK 506 in 36 patients undergoing renal transplan-tation. 1 This series was characterized by a high average complexity. and included 10 patients who also were liver recipients either concomitantly or at an earlier time. Additionally , 2 of the 10 also were given a heart or pancreas. We report here a follow-up of the 26 patients from that original...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: The Lancet
سال: 1989
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(89)91014-3